AllianceBernstein
LUMO

AllianceBernstein’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

AllianceBernstein’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4,733
Closed -$82K – 3202
2019
Q1 		$82K Sell
4,733
-1,067
-18% -$15.9K ﹤0.01% 3042
2018
Q4 		$79K Hold
5,800
– – ﹤0.01% 3016
2018
Q3 		$125K Hold
5,800
– – ﹤0.01% 3062
2018
Q2 		$248K Sell
5,800
-1,011
-15% -$46.3K ﹤0.01% 2883
2018
Q1 		$444K Hold
6,811
– – ﹤0.01% 2550
2017
Q4 		$497K Hold
6,811
– – ﹤0.01% 2525
2017
Q3 		$624K Hold
6,811
– – ﹤0.01% 2495
2017
Q2 		$451K Buy
6,811
+3,200
+89% +$396K ﹤0.01% 2651
2017
Q1 		$783K Sell
3,611
-656
-15% -$93.7K ﹤0.01% 2360
2016
Q4 		$395K Hold
4,267
– – ﹤0.01% 2639
2016
Q3 		$577K Sell
4,267
-200
-4% -$19.9K ﹤0.01% 2479
2016
Q2 		$453K Buy
4,467
+578
+15% +$71.6K ﹤0.01% 2552
2016
Q1 		$637K Hold
3,889
– – ﹤0.01% 2322
2015
Q4 		$1.27M Sell
3,889
-71
-2% -$23.1K ﹤0.01% 1974
2015
Q3 		$1.28M Sell
3,960
-7
-0.2% -$3.08K ﹤0.01% 1997
2015
Q2 		$1.58M Buy
3,967
+467
+13% +$198K ﹤0.01% 1984
2015
Q1 		$1.72M Sell
3,500
-178
-5% -$69K ﹤0.01% 1839
2014
Q4 		$1.32M Hold
3,678
– – ﹤0.01% 2034
2014
Q3 		$709K Hold
3,678
– – ﹤0.01% 2384
2014
Q2 		$879K Sell
3,678
-275
-7% -$55.9K ﹤0.01% 2323
2014
Q1 		$1.01M Sell
3,953
-156
-4% -$47.7K ﹤0.01% 2164
2013
Q4 		$814K Sell
4,109
-755
-16% -$134K ﹤0.01% 2255
2013
Q3 		$822K Buy
4,864
+8
+0.2% +$1.29K ﹤0.01% 2237
2013
Q2 		$862K Buy
+4,856
New +$688K ﹤0.01% 2165

Other funds holding LUMO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

AllianceBernstein's LUMO Position: Q2 2019 in Review

AllianceBernstein sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2019, closing a stake of 4,733 shares — an estimated $82K sold.

AllianceBernstein first reported a position in LUMO in Q2 2013 and held it in 24 quarters. The position peaked at $1.72M in Q1 2015. 68 funds tracked by Wall St. Rank hold LUMO as of Q2 2019.

  • AllianceBernstein reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • AllianceBernstein sold 4,733 Lumos Pharma, Inc. Common Stock shares in Q2 2019, an estimated $82K.
  • AllianceBernstein first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 24 quarters.
  • AllianceBernstein's Lumos Pharma, Inc. Common Stock position peaked at $1.72M in Q1 2015.
  • 68 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2019.

Based on AllianceBernstein's 13F filing for Q2 2019, filed 14 Aug 2019.